These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 20708697)

  • 1. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
    Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.
    Masic A; Booth JS; Mutwiri GK; Babiuk LA; Zhou Y
    J Virol; 2009 Oct; 83(19):10198-210. PubMed ID: 19625412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection.
    Pyo HM; Zhou Y
    Vaccine; 2014 Jun; 32(30):3835-42. PubMed ID: 24837774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine.
    Babiuk S; Masic A; Graham J; Neufeld J; van der Loop M; Copps J; Berhane Y; Pasick J; Potter A; Babiuk LA; Weingartl H; Zhou Y
    Vaccine; 2011 Apr; 29(17):3118-23. PubMed ID: 21382482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
    Kappes MA; Sandbulte MR; Platt R; Wang C; Lager KM; Henningson JN; Lorusso A; Vincent AL; Loving CL; Roth JA; Kehrli ME
    Vaccine; 2012 Jan; 30(2):280-8. PubMed ID: 22067263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
    Lee JH; Gramer MR; Joo HS
    Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
    Vincent AL; Ma W; Lager KM; Janke BH; Webby RJ; García-Sastre A; Richt JA
    Vaccine; 2007 Nov; 25(47):7999-8009. PubMed ID: 17933442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of maternally-derived antibodies on live attenuated influenza vaccine efficacy in pigs.
    Pyo HM; Hlasny M; Zhou Y
    Vaccine; 2015 Jul; 33(31):3667-72. PubMed ID: 26092308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
    Pearce MB; Belser JA; Houser KV; Katz JM; Tumpey TM
    Vaccine; 2011 Apr; 29(16):2887-94. PubMed ID: 21338676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.
    Kitikoon P; Vincent AL; Jones KR; Nilubol D; Yu S; Janke BH; Thacker BJ; Thacker EL
    Vet Microbiol; 2009 Nov; 139(3-4):235-44. PubMed ID: 19595522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.
    Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
    Vaccine; 2012 Apr; 30(20):3119-25. PubMed ID: 22391400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.